(GS) Goldman Sachs - Overview
Stock: Advisory, Underwriting, Lending, Trading, Asset Management
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.01% |
| Yield on Cost 5y | 6.94% |
| Yield CAGR 5y | 21.14% |
| Payout Consistency | 98.8% |
| Payout Ratio | 30.2% |
| Risk 5d forecast | |
|---|---|
| Volatility | 30.7% |
| Relative Tail Risk | -7.78% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.18 |
| Alpha | 27.35 |
| Character TTM | |
|---|---|
| Beta | 1.332 |
| Beta Downside | 1.341 |
| Drawdowns 3y | |
|---|---|
| Max DD | 30.90% |
| CAGR/Max DD | 1.28 |
Description: GS Goldman Sachs January 28, 2026
Goldman Sachs (NYSE:GS) operates a diversified financial-services platform across three core segments: Global Banking & Markets, which delivers advisory, underwriting, lending, and trading solutions; Asset & Wealth Management, which manages multi-class portfolios and provides private-banking services; and Platform Solutions, which offers consumer credit cards and corporate transaction-banking products. The firm serves corporations, governments, financial institutions, and individuals worldwide.
In FY 2025 the firm reported $58.2 billion in total revenue, a 4.1 % year-over-year increase driven primarily by a 7 % rise in Global Banking & Markets net revenue and a 3 % lift in Asset & Wealth Management fees. Net income reached $9.6 billion, translating to a return on equity of 14.2 %, while the Platform Solutions segment contributed $3.1 billion in revenue, up 5 % from the prior year.
Current macro-economic conditions that materially affect GS include: (1) a persistently elevated Federal Funds Rate (~5.3 % in Q4 2025) that sustains higher net interest margins on the firm’s lending activities; (2) a rebound in global M&A volume, which grew 12 % YoY in H1 2025, bolstering advisory fees; and (3) steady inflows into wealth-management assets, with AUM increasing 6 % to $2.4 trillion, reflecting client demand for diversified, inflation-hedged portfolios.
For a deeper, data-driven assessment of Goldman Sachs’ valuation dynamics, consider exploring the latest analytics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income: 17.18b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA 6.26 > 1.0 |
| NWC/Revenue: 95.13% < 20% (prev -66.93%; Δ 162.1% < -1%) |
| CFO/TA 0.01 > 3% & CFO 17.89b > Net Income 17.18b |
| Net Debt (455.00b) to EBITDA (21.81b): 20.86 < 3 |
| Current Ratio: 1.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (317.6m) vs 12m ago -3.29% < -2% |
| Gross Margin: 45.70% > 18% (prev 0.41%; Δ 4529 % > 0.5%) |
| Asset Turnover: 7.18% > 50% (prev 7.60%; Δ -0.42% > 0%) |
| Interest Coverage Ratio: 0.29 > 6 (EBITDA TTM 21.81b / Interest Expense TTM 66.81b) |
Altman Z'' 0.87
| A: 0.07 (Total Current Assets 684.00b - Total Current Liabilities 565.00b) / Total Assets 1810.00b |
| B: 0.09 (Retained Earnings 159.53b / Total Assets 1810.00b) |
| C: 0.01 (EBIT TTM 19.63b / Avg Total Assets 1742.99b) |
| D: 0.07 (Book Value of Equity 125.00b / Total Liabilities 1685.00b) |
| Altman-Z'' Score: 0.87 = B |
Beneish M -2.51
| DSRI: 1.25 (Receivables 186.00b/151.21b, Revenue 125.10b/127.34b) |
| GMI: 0.90 (GM 45.70% / 40.96%) |
| AQI: 1.70 (AQ_t 0.60 / AQ_t-1 0.35) |
| SGI: 0.98 (Revenue 125.10b / 127.34b) |
| TATA: -0.00 (NI 17.18b - CFO 17.89b) / TA 1810.00b) |
| Beneish M-Score: -2.51 (Cap -4..+1) = A |
What is the price of GS shares?
Over the past week, the price has changed by -0.71%, over one month by -2.80%, over three months by +18.51% and over the past year by +43.98%.
Is GS a buy, sell or hold?
- StrongBuy: 5
- Buy: 3
- Hold: 14
- Sell: 1
- StrongSell: 0
What are the forecasts/targets for the GS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 950.5 | 2.3% |
| Analysts Target Price | 950.5 | 2.3% |
| ValueRay Target Price | 1254.4 | 35.1% |
GS Fundamental Data Overview February 07, 2026
P/E Forward = 15.456
P/S = 4.7335
P/B = 2.1365
P/EG = 1.5766
Revenue TTM = 125.10b USD
EBIT TTM = 19.63b USD
EBITDA TTM = 21.81b USD
Long Term Debt = 285.63b USD (from longTermDebt, two quarters ago)
Short Term Debt = 333.00b USD (from shortTermDebt, last quarter)
Debt = 619.00b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 455.00b USD (from netDebt column, last quarter)
Enterprise Value = 402.15b USD (281.15b + Debt 619.00b - CCE 498.00b)
Interest Coverage Ratio = 0.29 (Ebit TTM 19.63b / Interest Expense TTM 66.81b)
EV/FCF = 25.50x (Enterprise Value 402.15b / FCF TTM 15.77b)
FCF Yield = 3.92% (FCF TTM 15.77b / Enterprise Value 402.15b)
FCF Margin = 12.61% (FCF TTM 15.77b / Revenue TTM 125.10b)
Net Margin = 13.73% (Net Income TTM 17.18b / Revenue TTM 125.10b)
Gross Margin = 45.70% ((Revenue TTM 125.10b - Cost of Revenue TTM 67.93b) / Revenue TTM)
Gross Margin QoQ = 44.32% (prev 46.17%)
Tobins Q-Ratio = 0.22 (Enterprise Value 402.15b / Total Assets 1810.00b)
Interest Expense / Debt = 2.69% (Interest Expense 16.67b / Debt 619.00b)
Taxrate = 21.14% (1.24b / 5.86b)
NOPAT = 15.48b (EBIT 19.63b * (1 - 21.14%))
Current Ratio = 1.21 (Total Current Assets 684.00b / Total Current Liabilities 565.00b)
Debt / Equity = 4.95 (Debt 619.00b / totalStockholderEquity, last quarter 125.00b)
Debt / EBITDA = 20.86 (Net Debt 455.00b / EBITDA 21.81b)
Debt / FCF = 28.85 (Net Debt 455.00b / FCF TTM 15.77b)
Total Stockholder Equity = 124.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.99% (Net Income 17.18b / Total Assets 1810.00b)
RoE = 13.81% (Net Income TTM 17.18b / Total Stockholder Equity 124.35b)
RoCE = 4.79% (EBIT 19.63b / Capital Employed (Equity 124.35b + L.T.Debt 285.63b))
RoIC = 3.24% (NOPAT 15.48b / Invested Capital 476.97b)
WACC = 4.84% (E(281.15b)/V(900.15b) * Re(10.82%) + D(619.00b)/V(900.15b) * Rd(2.69%) * (1-Tc(0.21)))
Discount Rate = 10.82% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.16%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈15.77b ; Y1≈10.35b ; Y5≈4.72b
Fair Price DCF = N/A (negative equity: EV 150.49b - Net Debt 455.00b = -304.51b; debt exceeds intrinsic value)
EPS Correlation: 48.34 | EPS CAGR: 7.29% | SUE: 2.19 | # QB: 6
Revenue Correlation: 83.99 | Revenue CAGR: 25.29% | SUE: 2.83 | # QB: 1
EPS next Quarter (2026-03-31): EPS=15.69 | Chg30d=+0.678 | Revisions Net=+10 | Analysts=18
EPS current Year (2026-12-31): EPS=58.36 | Chg30d=+2.953 | Revisions Net=+21 | Growth EPS=+13.7% | Growth Revenue=+9.8%
EPS next Year (2027-12-31): EPS=65.10 | Chg30d=+2.543 | Revisions Net=+11 | Growth EPS=+11.5% | Growth Revenue=+4.7%